120 related articles for article (PubMed ID: 2534927)
21. Studies of circulating immune complexes in ankylosing spondylitis.
Kinsella TD; Lanteigne C; Lewkonia RM; Fritzler MJ
Clin Invest Med; 1982; 5(4):223-30. PubMed ID: 7160109
[TBL] [Abstract][Full Text] [Related]
22. Differences among immune complexes: association of C1q in SLE immune complexes with renal disease.
Greisman SG; Redecha PB; Kimberly RP; Christian CL
J Immunol; 1987 Feb; 138(3):739-45. PubMed ID: 3492531
[TBL] [Abstract][Full Text] [Related]
23. [Quantitative characteristic of circulating immune complexes in patients with lupus erythematosus and central nervous system disorders].
Ivanova MM; Sykulev IuK; Blizniuk OI; Tumanova IA
Klin Med (Mosk); 1991 Mar; 69(3):58-60. PubMed ID: 2067339
[TBL] [Abstract][Full Text] [Related]
24. Analysis of Ig/Ig two-component-determined circulating immune complexes (TCIC) provide new insights into host immunity.
Wang S; Yang T; Zhang J; Xiao S; Peng X
Int Immunopharmacol; 2003 Oct; 3(10-11):1549-55. PubMed ID: 12946452
[TBL] [Abstract][Full Text] [Related]
25. DNA-anti-DNA circulating complexes in the nephritis of systemic lupus erythematosus.
Adu D; Dobson J; Williams DG
Clin Exp Immunol; 1981 Mar; 43(3):605-14. PubMed ID: 6974627
[TBL] [Abstract][Full Text] [Related]
26. Immune complexes in systemic sclerosis; detection by C1q binding, K-cell inhibition and Raji cell radioimmunoassays.
Hughes P; Cunningham J; Day M; Fitzgerald JC; French MA; Wright JK; Rowell NR
J Clin Lab Immunol; 1983 Mar; 10(3):133-8. PubMed ID: 6601718
[TBL] [Abstract][Full Text] [Related]
27. [Determination of immune complexes in renal diseases (author's transl)].
Smolen JS; Wolf A; Scherak O; Syre G; Pinggera W; Stummvoll HK; Leithner C; Menzel EJ
Acta Med Austriaca; 1981; 8(2):37-41. PubMed ID: 6456639
[TBL] [Abstract][Full Text] [Related]
28. Circulating immune complexes of IgG, IgA, and IgM classes in various glomerular diseases.
Doi T; Kanatsu K; Sekita K; Yoshida H; Nagai H; Hamashima Y
Nephron; 1982; 32(4):335-41. PubMed ID: 6762505
[TBL] [Abstract][Full Text] [Related]
29. Quantitative analyses of C3b capture and immune adherence of IgM antibody/dsDNA immune complexes.
Taylor RP; Wright EL; Pocanic F
J Immunol; 1989 Dec; 143(11):3626-31. PubMed ID: 2584711
[TBL] [Abstract][Full Text] [Related]
30. Diminished ability of erythrocytes from patients with systemic lupus erythematosus to limit opsonized immune complex deposition on leukocytes and activation of granulocytes.
Nielsen CH; Rasmussen JM; Voss A; Junker P; Leslie RG
Arthritis Rheum; 1998 Apr; 41(4):613-22. PubMed ID: 9550470
[TBL] [Abstract][Full Text] [Related]
31. Circulating immune complexes in IgA deficiency.
Kwitko AO; McKenzie PE; Shearman DJ; Gormly AA; Woodroffe AJ
Clin Exp Immunol; 1979 Oct; 38(1):45-51. PubMed ID: 527254
[TBL] [Abstract][Full Text] [Related]
32. A solid-phase, polyclonal IgM-RF binding assay for circulating immune complexes.
Glikmann G; Svehag SE; Nielsen H
Acta Pathol Microbiol Scand C; 1979 Apr; 87C(2):121-9. PubMed ID: 108921
[TBL] [Abstract][Full Text] [Related]
33. Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus.
Sekita K; Doi T; Muso E; Yoshida H; Kanatsu K; Hamashima Y
Clin Exp Immunol; 1984 Mar; 55(3):487-94. PubMed ID: 6608422
[TBL] [Abstract][Full Text] [Related]
34. Antibody and immune complexes induce tissue factor production by human endothelial cells.
Tannenbaum SH; Finko R; Cines DB
J Immunol; 1986 Sep; 137(5):1532-7. PubMed ID: 3745915
[TBL] [Abstract][Full Text] [Related]
35. Immune complex-like activity associated with abnormal serum lipoproteins in systemic erythematosus.
Smith GW; Hannan SF; Scott PJ; Simpson IJ
Clin Exp Immunol; 1982 Apr; 48(1):8-16. PubMed ID: 6979451
[TBL] [Abstract][Full Text] [Related]
36. IgM, IgG and IgA rheumatoid factors and circulating immune complexes in patients with AIDS and AIDS-related complex with serological abnormalities.
Procaccia S; Lazzarin A; Colucci A; Gasparini A; Forcellini P; Lanzanova D; Foppa CU; Novati R; Zanussi C
Clin Exp Immunol; 1987 Feb; 67(2):236-44. PubMed ID: 3608224
[TBL] [Abstract][Full Text] [Related]
37. [Demonstration of circulating immune complexes using a C1q-solid phase enzyme immunoassay].
Schössler W; Hiepe F; Courault K; Porstmann B; Apostoloff E
Biomed Biochim Acta; 1983; 42(7-8):1027-35. PubMed ID: 6360166
[TBL] [Abstract][Full Text] [Related]
38. Identification of components of IC purified from human sera. I. Immune complexes purified from sera of patients with SLE.
Maire MA; Barnet M; Carpentier N; Miescher PA; Lambert PH
Clin Exp Immunol; 1983 Feb; 51(2):215-24. PubMed ID: 6839539
[TBL] [Abstract][Full Text] [Related]
39. C1q-latex assay for immune complexes. Complexes that react with both C1q and monoclonal rheumatoid factor in lupus erythematosus and lung cancer.
Medof ME
J Lab Clin Med; 1982 May; 99(5):678-92. PubMed ID: 6978370
[TBL] [Abstract][Full Text] [Related]
40. Circulating immune complexes in Sjögren's syndrome.
Ichikawa Y; Takaya M; Arimori S
Tokai J Exp Clin Med; 1980 Oct; 5(4):367-74. PubMed ID: 6166090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
